More people are taking part in interventional clinical trials in the National Health Service than in recent years, but ...

J&J wants to maintain a leading position in prostate cancer with pasritamig and other agents, with first results from its ...

Estée Lauder unveils Mastering Skin Longevity innovation platform at the China International Import Expo, as PAI Partners ...

Primatene Mist Q3 sales reached brand record as Amphastar continues developing different propellant to protect its status as ...

The wellness takeover” across regions and demographics as consumers worldwide rank wellness second-highest priority, behind ...

BD’s fiscal fourth-quarter revenue rose 5.6% on a currency-neutral basis to $5.27bn, and adjusted EPS climbed 27.3% to $4.15.

Cardinal Health raised its fiscal 2027 non-GAAP EPS guidance to $12.80–$13 after first-quarter non-GAAP EPS rose to $3.26, ...

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. More than 40 documents ...

At AASLD, Madrigal is presenting real-world data supporting the benefits of long-term Rezdiffra treatment, while it plans a ...

The EGFRxMET-targeting bispecific antibody won accelerated approval from the US FDA for head and neck squamous cell carcinoma ...

Submitting promotional pieces to the Office of Prescription Drug Promotion for advisory comments, and then seeking further ...

Abbott reported at TCT 2026 that its investigational SonicForce coronary intravascular lithotripsy (IVL) system met its ...